Homocysteine
DEHomocystein
Reviewed by Maurice Lichtenberg
Homocysteine is a sulfur-containing amino acid produced during methionine metabolism and cleared via remethylation or transsulfuration pathways that depend on folate, vitamin B12, and vitamin B6. Elevated plasma homocysteine reflects impaired one-carbon metabolism and is associated with vascular endothelial dysfunction, atherosclerosis, and stroke; cognitive decline and dementia are observationally associated, but causality is uncertain. Major randomized trials of B-vitamin lowering (HOPE-2, NORVIT, VISP, SEARCH, VITATOPS) have not consistently reduced cardiovascular events overall, though some meta-analyses suggest a small reduction in stroke risk. Homocysteine is therefore interpreted as a risk and metabolic-health marker.
Sources
- Wald DS, Law M, Morris JK. (2002). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. *BMJ*doi:10.1136/bmj.325.7374.1202
- Wald DS, Kasturiratne A, Simmonds M. (2011). Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. *Alzheimer's & Dementia*doi:10.1016/j.jalz.2010.08.234
- Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, et al.. (2018). Homocysteine and dementia: an international consensus statement. *Journal of Alzheimer's Disease*doi:10.3233/JAD-171042
